Search results
Found 304 matches for
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future treatments.
New tool allows researchers to track how mutations arise in tissues
3 July 2025
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC WIMM community gathered for its flagship annual event, WIMM Day, on Tuesday 24th June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
RDM researchers edit new edition of seminal haematology textbook
1 May 2025
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
Adam Wilkinson wins 2025 ISEH Janet Rowley Award
13 March 2025
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
International Women's Day 2025
7 March 2025
For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.
Rare Disease Day 2025
27 February 2025
For Rare Disease Day on the 28th February, we spoke to three of our researchers about their work, discussing both the challenges and importance of researching and treating rare diseases.
Innovation at the MRC WIMM
17 February 2025
Here at the MRC Weatherall Institute of Molecular Medicine, we foster a strong culture of innovation.
Oxford Centre for Haematology Day 2025
29 January 2025
The fourth Oxford Centre for Haematology Day, held at the MRC WIMM on 28th January 2025, was a very successful afternoon. Talks covered some of the breadth of haematology research in Oxford.
MRC WIMM researchers win 2024 RDM Graduate Prize
28 January 2025
Congratulations to Charlotte Brierley and Patrick Pflughaupt, who were both awarded the 2024 RDM Graduate Prize after completing their PhDs at the MRC WIMM.
MRC WIMM Festive Decorating Competition 2024
20 December 2024
Teams across the MRC WIMM decorated their labs and offices with tinsel, handmade decorations and repurposed lab materials, filling the Institute with festive cheer.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
Senior Fellowship awarded to Beth Psaila
28 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
27 August 2024
Researchers from the MRC Molecular Haematology Unit (MHU) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
18 teams in the MRC WIMM receive LEAF Sustainability awards
17 July 2024
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research laboratories to embed sustainability into their work.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
WIMM Day 2024
28 June 2024
On Thursday 20th June 2024, the MRC Weatherall Institute of Molecular Medicine came together to share their research and celebrate the MRC WIMM community at Saïd Business School for WIMM Day 2024.
New Sculpture Unveiled at the MRC WIMM
3 June 2024
On Wednesday 29th May, a small group of institute members gathered to witness the unveiling of a new ceramic sculpture of a cell made by former MRC WIMM Group Leader Veronica Dudley (Buckle).